Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Ordinary Shares, par value $0.0001 per share
-
Shares outstanding
-
133,765,508
-
Total 13F shares
-
10,230,806
-
Share change
-
-369,889
-
Total reported value
-
$30,560,206
-
Put/Call ratio
-
43%
-
Price per share
-
$2.99
-
Number of holders
-
20
-
Value change
-
-$1,109,740
-
Number of buys
-
3
-
Number of sells
-
4
Institutional Holders of Global Cord Blood Corp - Ordinary Shares, par value $0.0001 per share (CORBF) as of Q4 2022
As of 31 Dec 2022,
Global Cord Blood Corp - Ordinary Shares, par value $0.0001 per share (CORBF) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,230,806 shares.
The largest 10 holders included
Oasis Management Co Ltd., Man Group plc, BlueCrest Capital Management Ltd, ISZO CAPITAL MANAGEMENT LP, NATIXIS ADVISORS, L.P., BANK OF AMERICA CORP /DE/, MORGAN STANLEY, NORTHERN TRUST CORP, MONETA GROUP INVESTMENT ADVISORS LLC, and AMERICAN CENTURY COMPANIES INC.
This page lists
20
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.